Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19728-57-5

19728-57-5

Post Buying Request

19728-57-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

19728-57-5 Usage

Chemical Properties

White powder

Check Digit Verification of cas no

The CAS Registry Mumber 19728-57-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,7,2 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 19728-57:
(7*1)+(6*9)+(5*7)+(4*2)+(3*8)+(2*5)+(1*7)=145
145 % 10 = 5
So 19728-57-5 is a valid CAS Registry Number.

19728-57-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail

  • Alfa Aesar

  • (H66152)  Nalpha-Benzyloxycarbonyl-DL-histidine, 98%   

  • 19728-57-5

  • 5g

  • 1173.0CNY

  • Detail

  • Alfa Aesar

  • (H66152)  Nalpha-Benzyloxycarbonyl-DL-histidine, 98%   

  • 19728-57-5

  • 25g

  • 2875.0CNY

  • Detail

19728-57-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(1H-imidazol-5-yl)-2-(phenylmethoxycarbonylamino)propanoic acid

1.2 Other means of identification

Product number -
Other names Cbz-DL-histidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19728-57-5 SDS

19728-57-5Relevant articles and documents

Tumor environment-induced ligand-expressing nanocarrier system

-

Sheet 3, (2010/02/11)

Drug delivery compositions for specific delivery of a drug to a tumor are described. These compositions include a core for sequestering the drug and a shell to which a ligand is attached for delivery of a drug to target cells. Since normal cells may also be targeted by the ligand, the compositions embed the ligand in the shell until the localized conditions surrounding the tumor cause the ligand to be displayed on the surface of the shell. One composition exhibits shrinkage of the shell at tumor pH, whereas another composition exhibits extension of the ligand at tumor pH. Still another composition causes the ligand to be exhibited at an elevated temperature.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19728-57-5